175 related articles for article (PubMed ID: 7486929)
1. Protein binding and serum bactericidal activities of vancomycin and teicoplanin.
Dykhuizen RS; Harvey G; Stephenson N; Nathwani D; Gould IM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1842-7. PubMed ID: 7486929
[TBL] [Abstract][Full Text] [Related]
2. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
[TBL] [Abstract][Full Text] [Related]
4. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.
Bailey EM; Rybak MJ; Kaatz GW
Antimicrob Agents Chemother; 1991 Jun; 35(6):1089-92. PubMed ID: 1834010
[TBL] [Abstract][Full Text] [Related]
5. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
Bowker KE; Noel AR; MacGowan AP
J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
[TBL] [Abstract][Full Text] [Related]
6. Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.
Knudsen JD; Fuursted K; Espersen F; Frimodt-Møller N
Antimicrob Agents Chemother; 1997 Sep; 41(9):1910-5. PubMed ID: 9303383
[TBL] [Abstract][Full Text] [Related]
7. Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.
Lai CC; Chen CC; Chuang YC; Tang HJ
Sci Rep; 2017 Jan; 7():41758. PubMed ID: 28139739
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
[TBL] [Abstract][Full Text] [Related]
9. Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.
Lepak A; Marchillo K; VanHecker J; Andes D
Antimicrob Agents Chemother; 2015 Dec; 59(12):7833-6. PubMed ID: 26392492
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously.
Van der Auwera P; Klastersky J
J Antimicrob Chemother; 1987 May; 19(5):623-35. PubMed ID: 2956228
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.
Bowker KE; Noel AR; MacGowan AP
J Antimicrob Chemother; 2006 Oct; 58(4):802-5. PubMed ID: 16891629
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.
Lagast H; Dodion P; Klastersky J
J Antimicrob Chemother; 1986 Oct; 18(4):513-20. PubMed ID: 2945811
[TBL] [Abstract][Full Text] [Related]
13. In-vitro bactericidal activity of cefpirome and cefamandole in combination with glycopeptides against methicillin-resistant Staphylococcus aureus.
Bergeret M; Raymond J
J Antimicrob Chemother; 1999 Feb; 43(2):291-4. PubMed ID: 11252338
[TBL] [Abstract][Full Text] [Related]
14. In vivo effect of teicoplanin and vancomycin upon haemolytic and bactericidal activity of serum against Staphylococcus aureus.
Rodríguez AB; Pedrera MI; Barriga C
Comp Immunol Microbiol Infect Dis; 1996 Sep; 19(4):283-8. PubMed ID: 8894378
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
16. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
17. Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus.
Stanley D; McGrath BJ; Lamp KC; Rybak MJ
Pharmacotherapy; 1994; 14(1):35-9. PubMed ID: 8159599
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.
Knudsen JD; Fuursted K; Raber S; Espersen F; Frimodt-Moller N
Antimicrob Agents Chemother; 2000 May; 44(5):1247-54. PubMed ID: 10770759
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
20. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
Cohen R; Barre J; Varon E
Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
